The oral S1P1 and S1P5 receptor agonist drug – now given the trade name Zeposia – was billed as one of the top 2020 drug launches to watch by Clarivate last month, before the COVID-19 outbreak ...

Zeposia, an ulcerative colitis medication, ran Z The Light, a direct-to-consumer campaign aimed at driving awareness, intent to ask doctors for the brand, prescriptions and brand equity. Summary of ...

NICE has issued a final “no” to Bristol-Myers Squibb’s oral MS drug Zeposia (ozanimod), in a decision that prevents access for patients in England and Wales. This ruling means that there ...